newdrugapprovals.org
Daratumumab Receives Breakthrough Therapy Designation From US Food and Drug Administration
May 1, 2013 Genmab A/S announced today that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for daratumumab for the treatment of patients with multiple myelom…